Coastlands Capital LP buys 25,000 shares of ADIL at $2.60; stock down 84.9% from 52-week high but up 69.2% in 90 days.
Coastlands Capital LP, a 10% owner, purchased 25,000 shares at $2.60 on 2026-06-29, increasing holdings by 7.2% to 373,322 shares. The transaction occurs with the stock trading at $2.86, substantially below the 52-week high of $18.90 but up 69.2% over 90 days, indicating recent recovery momentum after severe depreciation. ADIAL Pharmaceuticals reported a negative net income of $-2.0M and has a market capitalization of $6.1M, reflecting financial stress and extreme micro-cap status. The insider's track record shows only 1 prior buy across all tickers, providing limited context for interpreting whether this represents a sustained conviction pattern or an isolated opportunistic entry at current price levels.